Stay updated on Gene Transfer in X-Linked Myotubular Myopathy Clinical Trial
Sign up to get notified when there's something new on the Gene Transfer in X-Linked Myotubular Myopathy Clinical Trial page.

Latest updates to the Gene Transfer in X-Linked Myotubular Myopathy Clinical Trial page
- CheckyesterdayChange DetectedThe study’s listed locations were revised: Los Angeles, Toronto, Paris, and München now appear with updated location details, while several facility names and postal codes were removed. The study record’s update dates also advanced to November 2026.SummaryDifference0.7%

- Check8 days agoChange DetectedThe clinical trial record for the AT132 study in young children with XLMTM is displayed, including its study details, participation criteria, locations, and results information. It states that enrollment stopped after severe complications and fatalities associated with the treatment.SummaryDifference56%

- Check15 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice says NIH websites are changing and explains that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision marker changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe revision identifier in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Gene Transfer in X-Linked Myotubular Myopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Transfer in X-Linked Myotubular Myopathy Clinical Trial page.